Phibro Animal Health (PAHC) Net Equity Issued and Repurchased (2015 - 2019)
Phibro Animal Health (PAHC) posted quarterly Net Equity Issued and Repurchased of $793000.0 for Q1 2019, down 50.19% year-over-year from $1.6 million in Q1 2018, and up 510.0% quarter-over-quarter from $130000.0 in Q4 2018.
Phibro Animal Health (PAHC) Net Equity Issued and Repurchased (2015 - 2019) Analysis & Trends
Phibro Animal Health's Net Equity Issued and Repurchased history runs 5 years deep, the most recent figure standing at $793000.0 for Q1 2019.
- In Q1 2019, Net Equity Issued and Repurchased fell 50.19% year-over-year to $793000.0; the TTM figure through Jun 2019 stood at $1.1 million (down 80.1% YoY), while the FY2019 annual figure was $1.1 million, down 80.1% from the prior year.
- Net Equity Issued and Repurchased for Q1 2019 stood at $793000.0, up from $130000.0 in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $3.5 million in Q3 2017, with the low at $52000.0 in Q2 2016.
- The 5-year median for Net Equity Issued and Repurchased is $718000.0 (2015), against an average of $1.2 million.
- The sharpest annual moves came in 2017 and 2018: Net Equity Issued and Repurchased jumped 5594.23% in 2017, then plunged 93.95% in 2018.
- Phibro Animal Health's Net Equity Issued and Repurchased stood at $1.4 million in 2015, then tumbled by 96.25% to $52000.0 in 2016, then surged by 311.54% to $214000.0 in 2017, then tumbled by 39.25% to $130000.0 in 2018, then jumped by 510.0% to $793000.0 in 2019.
- Business Quant data shows PAHC's Net Equity Issued and Repurchased at $793000.0 in Q1 2019, $130000.0 in Q4 2018, and $211000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 125.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 793,000.00 |
| Mar 31, 2019 | 793,000.00 |
| Dec 31, 2018 | 130,000.00 |
| Dec 31, 2018 | 130,000.00 |
| Sep 30, 2018 | 211,000.00 |
| Sep 30, 2018 | 211,000.00 |
| Jun 30, 2018 | 407,000.00 |
| Jun 30, 2018 | 407,000.00 |
| Mar 31, 2018 | 1.59 Mn |
| Mar 31, 2018 | 1.59 Mn |
| Dec 31, 2017 | 214,000.00 |
| Dec 31, 2017 | 214,000.00 |
| Sep 30, 2017 | 3.49 Mn |
| Sep 30, 2017 | 3.49 Mn |
| Jun 30, 2017 | 2.96 Mn |
| Jun 30, 2017 | 2.96 Mn |
| Mar 31, 2017 | 2.47 Mn |
| Mar 31, 2017 | 2.47 Mn |
| Jun 30, 2016 | 52,000.00 |
| Jun 30, 2016 | 52,000.00 |